These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9404102)
1. [Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer]. Otsuka N; Tamada T; Mimura H; Sone T; Morita K; Tomomitsu T; Yanagimoto S; Fukunaga M Kaku Igaku; 1997 Oct; 34(10):939-43. PubMed ID: 9404102 [TBL] [Abstract][Full Text] [Related]
2. [Study on tumor accumulation property of 99mTc-HM-PAO and 99mTc-MIBI in rabbits bearing VX-2 cancer]. Otsuka N; Mimura H; Morita K; Ono S; Sone T; Nagai K; Yanagimoto S; Tomomitsu T; Asano T; Fukunaga M Kaku Igaku; 1995 Feb; 32(2):199-203. PubMed ID: 7715106 [TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. Arbab AS; Koizumi K; Toyama K; Arai T; Araki T J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934 [TBL] [Abstract][Full Text] [Related]
4. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines. Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948 [TBL] [Abstract][Full Text] [Related]
5. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo. Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628 [TBL] [Abstract][Full Text] [Related]
7. Effects of extracellular Na+ and Ca2+ ions and Ca2+ channel modulators on the cell-associated activity of 99mTc-MIBI and 99mTc-tetrofosmin in tumour cells. Arbab AS; Ueki J; Koizumi K; Araki T Nucl Med Commun; 2003 Feb; 24(2):155-66. PubMed ID: 12548040 [TBL] [Abstract][Full Text] [Related]
8. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487 [TBL] [Abstract][Full Text] [Related]
9. Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma. Kim SJ; Kim IJ; Kim YK Clin Nucl Med; 2002 Jan; 27(1):30-3. PubMed ID: 11805481 [TBL] [Abstract][Full Text] [Related]
10. [The assessment of 99mTc-HMPAO tumor scintigraphy using VX-2 tumors in rabbits]. Suga K; Uchisako H; Honma Y; Kuramitsu T; Itoh K; Nakagi K; Tanaka N; Ariyoshi I; Nakanishi T; Utsumi H Kaku Igaku; 1991 Sep; 28(9):1049-56. PubMed ID: 1770657 [TBL] [Abstract][Full Text] [Related]
11. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130 [TBL] [Abstract][Full Text] [Related]
12. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines. Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728 [TBL] [Abstract][Full Text] [Related]
13. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704 [TBL] [Abstract][Full Text] [Related]
14. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection. Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells. Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721 [TBL] [Abstract][Full Text] [Related]
16. Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines. Rodrigues M; Kalinowska W; Zielinski C; Sinzinger H Nucl Med Commun; 2001 Jun; 22(6):645-50. PubMed ID: 11403175 [TBL] [Abstract][Full Text] [Related]
17. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. Arbab AS; Koizumi K; Toyama K; Araki T J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217 [TBL] [Abstract][Full Text] [Related]
18. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi. Ding HJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A Appl Radiat Isot; 2002 Jun; 56(6):853-6. PubMed ID: 12102342 [TBL] [Abstract][Full Text] [Related]
19. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects. Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474 [TBL] [Abstract][Full Text] [Related]
20. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]